Human papillomavirus in early laryngeal carcinoma

Laryngoscope

Volumn 119, Issue 8, 2009, Pages 1531-1537

  Baumann, Jessica L ^a   Cohen, Seth ^a   Evjen, Amy N ^a   Law, Jonathan H ^a   Vadivelu, Sangeetha ^a   Attia, Albert ^a   Schindler, Joshua S ^e   Chung, Christine H ^a   Wirth, Pamela S ^a   Meijer, Chris J L M ^c   Snijders, Peter J F ^d   Yarbrough, Wendell G ^a   Slebos, Robbert J C ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Carcinoma in situ; Head and neck squamous cell carcinoma; Human papilloma virus; Larynx carcinoma

Indexed keywords

PROTEIN P16; VIRUS DNA;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; EARLY CANCER; FEMALE; GROUPS BY AGE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 52; IN SITU HYBRIDIZATION; LARYNX CARCINOMA; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCREENING TEST; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS TYPING; WART VIRUS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA IN SITU; CASE-CONTROL STUDIES; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; STATISTICS, NONPARAMETRIC; TUMOR VIRUS INFECTIONS;

EID: 68849086441     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20509     Document Type: Article

References (31)

1. Ries L, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2005. Bethesda, MD: National Cancer Institute; 2008.
2. Marshall JR, Graham S, Haughey BP, et al. Smoking, alcohol, dentition and diet in the epidemiology of oral cancer. Eur J Cancer B Oral Oncol 1992;28B:9-15.
3. Syrjanen KJ, Surjanen SM. Histological evidence for the presence of condylomatous epithelial lesions in assoction with laryngeal squamous cell carcinoma. ORL J Oto- rhinolaryngol Relat Spec 1981;43:181-194.
4. Bernard HU, Calleja-Macias IE, Dunn ST. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 2006;118:1071-1076.
5. Hobbs CG, Birchall MA. Human papillomavirus infection in the etiology of laryngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg 2004;12:88-92.
6. Torrente MC, Ampuero S, Abud M, Ojeda JM. Molecular detection and typing of human papillomavirus in laryn- geal carcinoma specimens. Acta Otolaryngol 2005;125:888-893.
7. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005;32(Suppl 1):S59-66.
8. Syrjanen K, Syrjanen S. Papillomavirus Infections in Human Disease. New York: Wiley; 2000:1-615.
9. Rady PL, Schnadig VJ, Weiss RL, Hughes TK, Tyring SK. Malignant transformation of recurrent respiratory papil- lomatosis associated with integrated human papillomavi- rus type 11 DNA and mutation of p53. Laryngoscope 1998;108:735-740.
10. Torrente MC, Ojeda JM. Exploring the relation between human papilloma virus and larynx cancer. Acta Otolaryn-gol 2007;127:900-906.
11. Gillison ML, Lowy DR. A causal role for human papilloma- virus in head and neck cancer. Lancet 2004;363:1488-1489.
12. Agudelo D, Quer M, Leon X, Diez S, Burgues J. Laryngeal carcinoma in patients without a history of tobacco and alcohol use. Head Neck 1997;19:200-204.
13. Pintos J, Franco EL, Black MJ, Bergeron J, Arella M. Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract. Cancer 1999;85:1903-1909.
14. Slebos RJ, Boerrigter L, Evers SG, Wisman P, Mooi WJ, Rodenhuis S. A rapid and simple procedure for the routine detection of ras point mutations in formalin-fixed, paraffin-embedded tissues. Diagn Mol Pathol 1992;1:136-141.
15. Snijders PJ, van den Brule AJ, Jacobs MV, Pol RP, Meijer CJ. HPV DNA detection and typing in cervical scrapes. Methods Mol Med 2005;119:101-114.
16. Gorgoulis VG, Zacharatos P, Kotsinas A, et al. Human pap- illoma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 1999;30:274-283.
17. Herrero R, Castellsague X, Pawlita M, et al. Human papil-lomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003;95:1772-1783.
18. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-698.
19. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-720.
20. Gillison ML. Human papillomavirus-related diseases: oro- pharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health 2008;43:S52-60.
21. Resnick RM, Cornelissen MT, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990;82:1477-1484.
22. Snijders PJ, Scholes AG, Hart CA, et al. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 1996;66: 464-469.
23. Fouret P, Monceaux G, Temam S, Lacourreye L, St Guily JL. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch Otolaryngol Head Neck Surg 1997;123:513-516.
24. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005;14:467-475.
25. Qu W, Jiang G, Cruz Y, et al. PCR detection of human pap-illomavirus: comparison between MY09/MY11 and GP5+/ GP6+ primer systems. J Clin Microbiol 1997;35:1304-1310.
26. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Micro- boil 2000;38:357-361.
27. Fouret P, Dabit D, Sibony M, et al. Expression of p53 protein related to the presence of human papillomavirus infection in precancer lesions of the larynx. Am J Pathol 1995;146:599-604.
28. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527. (Pubitemid 36159887)
29. Smith EM, Wang D, Kim Y, et al. P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol 2008;44:133-142. (Pubitemid 351179656)
30. Kong CS, Balzer BL, Troxell ML, Patterson BK, Longacre TA. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am J Surg Pathol 2007;31:33-43.
31. Vinokurova S, Wentzensen N, von Knebel Doeberitz M. Analysis of p16INK4a and integrated HPV genomes as progression markers. Methods Mol Med 2005;119:73-83.